Search Results - Menzen, Markus

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Risk of solid cancer in patients with mast cell activation syndrome: Results from Germany and USA

    Risk of solid cancer in patients with mast cell activation syndrome: Results from Germany and USA by Molderings, Gerhard J., Zienkiewicz, Thomas, Homann, Jürgen, Menzen, Markus, Afrin, Lawrence B.

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Pharmacological treatment options for mast cell activation disease

    Pharmacological treatment options for mast cell activation disease by Molderings, Gerhard J., Haenisch, Britta, Brettner, Stefan, Homann, Jürgen, Menzen, Markus, Dumoulin, Franz Ludwig, Panse, Jens, Butterfield, Joseph, Afrin, Lawrence B.

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes

    Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes by Aberle, Jens, Menzen, Markus, Schmid, Sebastian M., Terkamp, Christoph, Jaeckel, Elmar, Rohwedder, Katja, Scheerer, Markus F., Xu, John, Tang, Weifeng, Birkenfeld, Andreas L.

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: